One of the most expensive disorders in terms of both treatment and productivity costs is depression.  To make matters worse depression rates are rising even in advance of WHO predictions that by 2020 the cost of treating depression would outweight the cost of treating all of the cardio-vascular diseases combined.

And yet we continue to use 2 universally inadequate methods to treat depression, CBT and medication. Studies show that these methods have a very low success rate, fail to protect the patient against relapse, and (in Australia) cost approximately $17,000 per patient per annum to treat.

BMSA treatment is mostly unavailable to sufferers of depression, despite the fact that BMSA (Brief, Multi-Sensory Activation) therapy has been demonstrated to be many times more effective than CBT or the SSRI's, faster to produce relief, less likely to be followed by relapse, easier for the patient to learn to self treat, and almost 90% cheaper to administer.

We need a less politicised delivery of psychology practice, and more focus on efficacy. Less "flavour of the month" (or decade) and more evidence.